AMPA receptor potentiators: from drug design to cognitive enhancement
KM Partin - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Better AMPAR positive allosteric modulators are being developed.•New
methodologies and approaches enhance the analysis of their activity in vitro.•AMPA positive …
methodologies and approaches enhance the analysis of their activity in vitro.•AMPA positive …
[HTML][HTML] AMPA RECEPTOR POTENTIATORS: FROM DRUG DESIGN TO COGNITIVE ENHANCEMENT
KM PARTIN - Current opinion in pharmacology, 2015 - ncbi.nlm.nih.gov
Positive allosteric modulators of ionotropic glutamate receptors have emerged as a target for
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
[引用][C] AMPA receptor potentiators: from drug design to cognitive enhancement
KM Partin - Current Opinion in Pharmacology, 2015 - cir.nii.ac.jp
AMPA receptor potentiators: from drug design to cognitive enhancement.
KM Partin - Current Opinion in Pharmacology, 2014 - europepmc.org
Positive allosteric modulators of ionotropic glutamate receptors have emerged as a target for
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
AMPA receptor potentiators: from drug design to cognitive enhancement
KM Partin - Current Opinion in Pharmacology, 2015 - infona.pl
Positive allosteric modulators of ionotropic glutamate receptors have emerged as a target for
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
AMPA receptor potentiators: from drug design to cognitive enhancement
KM Partin - Current opinion in pharmacology, 2015 - pubmed.ncbi.nlm.nih.gov
Positive allosteric modulators of ionotropic glutamate receptors have emerged as a target for
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
AMPA receptor potentiators: from drug design to cognitive enhancement.
KM Partin - Current Opinion in Pharmacology, 2014 - europepmc.org
Positive allosteric modulators of ionotropic glutamate receptors have emerged as a target for
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …
treating cognitive impairment and neurodegeneration, but also mental illnesses such as …